← Back
Data updated: Jun 28, 2026
ROYAL PHARMS
Pharma Pharmaceuticals
ROYAL PHARMS is a pharmaceutical company with 1 FDA-approved products.
2025
Since
1
Drugs
-
Trials
1
New Drugs (2yr)
ROYAL PHARMS's Key Drugs
ROYAL PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
ROYAL PHARMS's Recent FDA Approvals
ROYAL PHARMS secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
ROYAL PHARMS's Therapeutic Areas
Disease areas where ROYAL PHARMS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
ROYAL PHARMS Pipeline Snapshot
Active clinical trials for ROYAL PHARMS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2025-10-23
- Latest
- 2025-10-23
- Applications
- 1